Welcome to the AHS 2020 ePoster Session. Please scroll down to view all of the submitted posters or press Control-F to search. To view the poster and its abstract, click on the poster image. Many posters also have a brief audio introduction which can be played by going to the bottom of the poster screen.
P031: OUTCOMES OF A REINFORCED BIOLOGIC MESH APPLIED IN 65 HERNIAS UNDERGOING RTAPP REPAIR
Cory J Banaschak, DO1; Paul Szotek, MD2; 1Ascension St. Vincent Hospital; 2Indiana Hernia Center
The objective of this study is to evaluate the utilization of reinforced biologic mesh during robotic transabdominal preperitoneal (rTAPP) inguinal hernia repair. All patients with inguinal hernias undergoing rTAPP by a single surgeon at least 1 year out from repair were identified. Patients that received placement of the reinforced biologic mesh were selected for review. Patients with prior hernia repairs and patients with bilateral repairs were also included. All repairs were completed utilizing the same rTAPP technique which included placement of a permanent anchoring stich in Cooper’s ligament and two interrupted anchoring sutures on the anterior abdominal wall for fixation after deployment of the mesh. All patients were followed post-operatively utilizing a HIPAA compliant two-way messaging application for communication between the patient and surgeon regarding postoperative management and any concerns that developed at any time post-operatively.
From June 2018 to April 2019, a total of 49 patients undergoing rTAPP with the same reinforced biologic mesh (Ovitex 1S) were identified, and 6 of these patients had previously undergone repair. There were 14 left, 19 right, and 16 bilateral inguinal hernias, for a total of 65 repaired hernias. Some patients also had simultaneous repair of other conditions at the time of rTAPP, including ventral hernia repair (n=5), hydrocelectomy (n=2), and mesh or plug excision (n=1). Follow-up duration ranged from 371 to 681 days. During this period, no patients have been identified to develop recurrence. Also, no surgical site infections or surgical site occurrences have been identified.
These 65 inguinal hernia repairs are at least 1 year out from rTAPP repair utilizing the same reinforced biologic mesh. Interestingly, in this group, no recurrences or complications have been identified with active follow-up conducted via the application previously mentioned. In conclusion, the use of a reinforced biologic mesh appears to be a viable option for rTAPP inguinal hernia repairs in patients who desire the robotic assisted minimally invasive technique while avoiding traditional permanent synthetic mesh. Continued long term follow up is warranted.
Click the image below to expand: